β4‑integrin‑mediated cytotoxic activity of AexU in human prostate cancer PC3 cells

Kumano,Masafumi; Miyake,Hideaki; Abolghait,Said  K.; Behnsawy,Hosny  M.; Fujisawa,Masato

doi:10.3892/ol.2013.1542

β4‑integrin‑mediated cytotoxic activity of AexU in human prostate cancer PC3 cells

Authors:
- Masafumi Kumano
- Hideaki Miyake
- Said K. Abolghait
- Hosny M. Behnsawy
- Masato Fujisawa
View Affiliations

Affiliations: Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt
Published online on: August 23, 2013 https://doi.org/10.3892/ol.2013.1542
Pages: 1482-1486

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to characterize the cytotoxic activity of AexU, an effector‑mediating type three secretion system (TTSS) of gram‑negative bacteria, in human prostate cancer cells, focusing on the association with β4‑integrin expression. The cytotoxic effects of AexU either alone or in combination with chemotherapeutic agents were evaluated using several human prostate cancer cell lines. Human prostate cancer PC3 cells, in which an expression vector containing siRNA targeting β4‑integrin had been introduced, were established (PC3/sh‑In), and the cytotoxic effects of AexU on the PC3/sh‑In cells were compared with the PC3 cells that were transfected with a control vector (PC3/C). The expression levels of β4‑integrin in the PC3 cells were markedly higher compared with those in the LNCaP or DU145 cells, and the cytotoxic effects of AexU in the PC3 cells were more pronounced compared with those in the LNCaP or DU145 cells. The sensitivity of the PC3 cells to docetaxel and cisplatin was significantly enhanced following treatment with AexU, resulting in a decrease in the IC50 of the two agents by ~90%. The cytotoxic effect of AexU in the PC3/C cells was more marked compared with that in the PC3/sh‑In cells, and the phosphorylation of Akt in the PC3/C cells appeared to be significantly more inhibited by the treatment with AexU compared with the PC3/sh‑In cells. In conclusion, treatment with AexU may be a useful therapeutic option for prostate cancer when β4‑integrin is overexpressed. The treatment appears to exert its effects through growth inhibition and by enhancing the sensitivity of the cancer cells to chemotherapeutic agents.

View Figures

View References

1	Ghosh P: Process of protein transport by the type III secretion system. Microbiol Mol Biol Rev. 68:771–795. 2004. View Article : Google Scholar : PubMed/NCBI
2	Braun M, Stuber K, Schlatter Y, Wahli T, Kuhnert P and Frey J: Characterization of an ADP-ribosyltransferase toxin (AexT) from Aeromonas salmonicida subsp salmonicida. J Bacteriol. 184:1851–1858. 2002. View Article : Google Scholar : PubMed/NCBI
3	Sha J, Wang SF, Suarez G, et al: Further characterization of a type III secretion system (T3SS) and of a new effector protein from a clinical isolate of Aeromonas hydrophila - part I. Microb Pathog. 43:127–146. 2007. View Article : Google Scholar : PubMed/NCBI
4	Sierra JC, Suarez G, Sha J, et al: Biological characterization of a new type III secretion system effector from a clinical isolate of Aeromonas hydrophila-part II. Microb Pathog. 43:147–160. 2007. View Article : Google Scholar : PubMed/NCBI
5	Khajanchi BK, Sha J, Kozlova EV, et al: N-acylhomoserine lactones involved in quorum sensing control the type VI secretion system, biofilm formation, protease production, and in vivo virulence in a clinical isolate of Aeromonas hydrophila. Microbiology. 155:3518–3531. 2009. View Article : Google Scholar
6	LaFlamme SE, Nieves B, Colello D and Reverte CG: Integrins as regulators of the mitotic machinery. Curr Opin Cell Biol. 20:576–582. 2008. View Article : Google Scholar : PubMed/NCBI
7	Gilcrease MZ: Integrin signaling in epithelial cells. Cancer Lett. 247:1–25. 2007. View Article : Google Scholar
8	Guo W and Giancotti FG: Integrin signalling during tumour progression. Nat Rev Mol Cell Biol. 5:816–826. 2004. View Article : Google Scholar : PubMed/NCBI
9	Vicente-Manzanares M, Choi CK and Horwitz AR: Integrins in cell migration - the actin connection. J Cell Sci. 122:199–206. 2009. View Article : Google Scholar : PubMed/NCBI
10	Abolghait SK, Iida T, Kodama T, Cantarelli VV, Akeda Y and Honda T: Recombinant AexU effector protein of Aeromonas veronii bv. sobria disrupts the actin cytoskeleton by downregulation of Rac1 and induces direct cytotoxicity to β4-integrin expressing cell lines. Microb Pathog. 51:454–465. 2011.PubMed/NCBI
11	Choi YP, Kim BG, Gao MQ, Kang S and Cho NH: Targeting ILK and β4 integrin abrogates the invasive potential of ovarian cancer. Biochem Biophys Res Commun. 427:642–648. 2012.
12	Gerson KD, Shearstone JR, Maddula VS, Seligmann BE and Mercurio AM: Integrin β4 regulates SPARC protein to promote invasion. J Biol Chem. 287:9835–9844. 2012.
13	Drake JM, Barnes JM, Madsen JM, Domann FE, Stipp CS and Henry MD: ZEB1 coordinately regulates laminin-332 and β4 integrin expression altering the invasive phenotype of prostate cancer cells. J Biol Chem. 285:33940–33948. 2010.PubMed/NCBI
14	Bonaccorsi L, Carloni V, Muratori M, et al: Androgen receptor expression in prostate carcinoma cells suppresses alpha6beta4 integrin-mediated invasive phenotype. Endocrinology. 141:3172–3182. 2000.
15	Davis TL, Cress AE, Dalkin BL and Nagle RB: Unique expression pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinoma. Prostate. 46:240–248. 2001. View Article : Google Scholar : PubMed/NCBI
16	Terakawa T, Miyake H, Furukawa J, Ettinger SL, Gleave ME and Fujisawa M: Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells. Br J Cancer. 101:1731–1739. 2009. View Article : Google Scholar : PubMed/NCBI
17	Kususda Y, Miyake H, Gleave ME and Fujisawa M: Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model. Br J Cancer. 106:1945–1952. 2012. View Article : Google Scholar : PubMed/NCBI
18	Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin. 56:106–130. 2006. View Article : Google Scholar
19	Bluemn EG and Nelson PS: The androgen/androgen receptor axis in prostate cancer. Curr Opin Oncol. 24:251–257. 2012. View Article : Google Scholar : PubMed/NCBI
20	Haddad H and Garcia JA: Novel agents for the management of castration-resistant prostate cancer. Curr Opin Urol. 22:175–182. 2012. View Article : Google Scholar : PubMed/NCBI
21	Kurita A, Gotoh H, Eguchi M, et al: Intracellular expression of the Salmonella plasmid virulence protein, SpvB, causes apoptotic cell death in eukaryotic cells. Microb Pathog. 35:43–48. 2003.
22	Bhattacharjee RN, Park KS, Kumagai Y, et al: VP1686, a Vibrio type III secretion protein, induces toll-like receptor-independent apoptosis in macrophage through NF-kappaB inhibition. J Biol Chem. 281:36897–36904. 2006. View Article : Google Scholar : PubMed/NCBI
23	Molero C, Rodríguez-Escudero I, Alemán A, Rotger R, Molina M and Cid VJ: Addressing the effects of Salmonella internalization in host cell signaling on a reverse-phase protein array. Proteomics. 9:3652–3665. 2009.